Netherlands· NL-929d918bf83a

Leustatin, concentraat voor infusievloeistof 1 mg/ml

A cladribine product containing cladribine, registered in Netherlands by Atnahs Pharma Netherlands B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC L01BB04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cladribineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cladribine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01BB04 (cladribine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search cladribine products by name

Cladribine · ATC L01BB04

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CLADRIBINE
Manufacturer: Atnahs Pharma Netherlands B.V.
Country: Netherlands (NL)
ATC code: L01BB04
ATC class: Cladribine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
16844

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

409 interactions on record for cladribine.

Graded by severity as the source publishes them — 326 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cladribine against other medicines How interaction checks work

Cladribine · interactions on record

409 records

326 severe
79 moderate
4 info

Most severe, free to view

PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe
BetamethasoneA07EA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cladribine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cladribine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Leuject
Belgium · Leustatin
Bulgaria · Леуджект
Czechia · Leuject
Germany · Leustatin
Spain · Leustatin
Finland · Leuject
France · Leustatine
United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
Greece · Leustatin
Croatia · Leuject
Hungary · Leuject
Iceland · Mavenclad
Italy · Leustatin
Liechtenstein · Mavenclad
Luxembourg · Leustatin
Norway · Leuject, Mavenclad
Poland · Biodribin, Leuject
Portugal · Cladribina Generis, Leustatin
Romania · Leuject
Sweden · Leuject
Slovenia · Leuject

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4aff52cf-baf5-4159-b793-0285ce26d69e
GET /v1/drugs/4aff52cf-baf5-4159-b793-0285ce26d69e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16844_smpc.pdf",
  "strength": null,
  "atc_label": "Cladribine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16844",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
    "FOSFORZUUR (E 338)",
    "NATRIUMCHLORIDE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CLADRIBINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16844.pdf",
  "authorised_at": "1995/02/15",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "16844",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about cladribine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console